文献速递咽喉与嗓音

组蛋白变体作为干细胞生物标志物用于长期注射内移喉成形术

Histone Variants as Stem Cell Biomarkers for Long-Term Injection Medialization Laryngoplasty.
PubMed 文献 · Laryngoscope · 2018-09-12

研究在兔声带麻痹模型中联合注射脂肪间充质干细胞(ADSC)与微粒化脱细胞真皮(MACD),12周后经质谱蛋白质组学分析发现,ADSC组独特表达333种蛋白,组蛋白家族显著富集,其中H3.3、H2A.V、H2A.Z等开放染色质相关变体过表达,而结构型组蛋白未过表达。结论提示非典型组蛋白等标志物与ADSC体内增殖及声带内移体积扩大相关。

要点

  • ADSC联合MACD注射后12周,组蛋白变体H3.3、H2A.V、H2A.Z在ADSC组过表达
  • 结构型组蛋白H2A、H2B、H4未在ADSC组过表达
  • 组蛋白家族在ADSC组蛋白GO分类中显著过表达(P < 0.05)

核心结论

  • 非典型组蛋白等生物标志物与ADSC体内增殖及声带内移体积扩大相关。

研究设计与样本

  • 兔声带麻痹模型,比较MACD、MACD+未分化ADSC、MACD+软骨细胞微球三组,12周后取喉组织行质谱蛋白质组学分析。

主要发现

  • 确认蛋白数:MACD组147种,MACD+ADSC组1243种,MACD+CHON组1033种。
  • MACD+ADSC组独特发现333种蛋白,包括间充质表面标志物CD9、CD44、纤连蛋白和波形蛋白。
  • 超过70%的蛋白属于催化活性和结合GO分类,组蛋白家族显著过表达(P < 0.05)。
  • 组蛋白变体H3.3、H2A.V、H2A.Z在MACD+ADSC组过表达,结构型组蛋白H2A、H2B、H4未过表达。

临床怎么用

  • 组蛋白变体H3.3、H2A.V、H2A.Z可作为评估ADSC在声带内移注射后体内增殖潜能的候选生物标志物。

局限性

  • 证据水平为NA,研究为兔模型,结论外推至临床需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES/HYPOTHESIS: Vocal fold (VF) paralysis by sectioning the recurrent laryngeal nerve dramatically impacts the life of thyroidectomy patients. Volume-expanding materials can temporarily restore VF medialization. To prolong this benefit, adipose mesenchymal stem cells (ADSCs) and micronized acellular dermis (MACD) were co-injected in a rabbit model of injection medialization laryngoplasty. Biomarkers of in situ proliferation were identified by mass spectrometry proteomics and pathway analysis to guide future efforts to increase the length of benefit. METHODS: ADSCs were expanded and/or differentiated into chondrocytes (CHON) as collagen microspheres. After VF paralysis rabbits received MACD, MACD + undifferentiated ADSC, or MACD+CHON, ADSCs differentiated into chondrocytes. After 12 weeks, animals were sacrificed and 5-µm paraffin-embedded cryosections were prepared from larynges for hematoxylin and eosin visualization and nanoflow liquid chromatography electrospray-ionization tandem-mass spectrometry analysis of tissue collections. Validated proteins were processed by Venn subtraction and gene ontology (GO) overrepresentation analysis to identify unique pathways and biomarkers. RESULTS: Confirmed proteins numbered 147 (MACD), 1,243 (MACD+ADSC), and 1,033 (MACD+CHON). Totally, 333 proteins were uniquely found in the MACD+ADSC group, including mesenchymal surface markers CD9, CD44, fibronectin, and vimentin. Over 70% of proteins belonged to catalytic activity and binding GO categories, with the histone (H) family being overrepresented (P < 0.05). Histone variants H3.3, H2A.V, and H2A.Z (associated with open chromatin states) were overrepresented in the MACD+ADSC group, whereas structural histones H2A, H2B, and H4 were not. CONCLUSION: Biomarkers, including atypical histones, are associated with in vivo proliferation of ADSCs and an expanded VF medialization volume. LEVEL OF EVIDENCE: NA Laryngoscope, 128:E402-E408, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Voss S, San-Marina S, Oldenburg MS, et al. Histone Variants as Stem Cell Biomarkers for Long-Term Injection Medialization Laryngoplasty. Laryngoscope. 2018. PMID: 30208202. doi:10.1002/lary.27429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。